PRTG: A Protein Targeted for Cancer and Other Diseases (G283659)

Target Name: PRTG

NCBI ID: G283659

PRTG

PRTG: A Protein Targeted for Cancer and Other Diseases

PRTG, also known as shen-dan, is a drug target and a biomarker that is currently being studied for its potential in treating various diseases, including cancer. PRTG is a protein that is expressed in various tissues throughout the body, including the brain, and has been shown to play a role in a number of important cellular processes.

One of the key functions of PRTG is its role in the regulation of cell growth and division. PRTG has been shown to be involved in the formation of cell plates, which are the sites where new cells are born, and in the regulation of cell division. This is important because changes in cell division and growth can contribute to the development of a variety of diseases, including cancer.

Another function of PRTG is its role in the regulation of cell death. PRTG has been shown to be involved in the formation of apoptotic cells, which are cells that are programmed to die as a result of environmental or genetic stress. This is important because the regulation of cell death is important for maintaining the health and function of tissues and organs.

In addition to its role in cell growth and division, PRTG has also been shown to be involved in the regulation of pain and inflammation. This is important because pain and inflammation can contribute to the development and progression of a variety of diseases.

PRTG has also been shown to have potential as a drug target in cancer. By targeting PRTG with drugs, researchers hope to inhibit its ability to regulate cell growth and division, which can lead to the development of cancer cells. This is an important goal because cancer is a leading cause of death in the world, and new treatments are always needed to help treat this disease.

In addition to its potential as a cancer drug target, PRTG has also been shown to be a potential biomarker for several other diseases. For example, PRTG has been shown to be involved in the regulation of brain function, and has been linked to a number of neurological disorders, including Alzheimer's disease. This is important because the regulation of brain function is important for maintaining the health and function of the brain, and understanding how PRTG is involved in this process could lead to the development of new treatments for neurological disorders.

Overall, PRTG is a protein that is expressed in various tissues throughout the body and has been shown to play a number of important roles in cellular processes. Its potential as a drug target and biomarker make it an important area of research for the development of new treatments for a variety of diseases.

Protein Name: Protogenin

Functions: May play a role in anteroposterior axis elongation

The "PRTG Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRTG comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets